About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Modafinil
- Procedure number
- PSUSA/00010242/202108
- Regulatory outcome
- Variation
Documents
Modafinil : List of nationally authorised medicinal products - PSUSA/00010242/202108
English (EN) (137.93 KB - PDF)
Modafinil : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010242/202108
English (EN) (39.77 KB - PDF)
български (BG) (94.42 KB - PDF)
español (ES) (32.51 KB - PDF)
čeština (CS) (72.07 KB - PDF)
dansk (DA) (27.23 KB - PDF)
Deutsch (DE) (34.5 KB - PDF)
eesti keel (ET) (39.91 KB - PDF)
ελληνικά (EL) (87.13 KB - PDF)
français (FR) (31.81 KB - PDF)
hrvatski (HR) (79.54 KB - PDF)
íslenska (IS) (30.47 KB - PDF)
italiano (IT) (32.66 KB - PDF)
latviešu valoda (LV) (85.57 KB - PDF)
lietuvių kalba (LT) (90.8 KB - PDF)
magyar (HU) (76.09 KB - PDF)
Malti (MT) (82.17 KB - PDF)
Nederlands (NL) (37.03 KB - PDF)
norsk (NO) (36.08 KB - PDF)
polski (PL) (84.55 KB - PDF)
português (PT) (32.28 KB - PDF)
română (RO) (78.76 KB - PDF)
slovenčina (SK) (79.24 KB - PDF)
slovenščina (SL) (79.02 KB - PDF)
Suomi (FI) (35.84 KB - PDF)
svenska (SV) (41.41 KB - PDF)